Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01437397 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1692

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Aclidinium Bromide/Formoterol Fumarate
DRUG: Aclidinium Bromide/Formoterol Fumarate
DRUG: Aclidinium Bromide
DRUG: Formoterol Fumarate
DRUG: Placebo

Sponsor

AstraZeneca